Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXER-MED: Exercise and Tirzepatide in Overweight and Obesity
NCT07298915Phase 3Not yet recruiting
- Sponsor
- University of Virginia
- Start
- Aug 2026
- Primary completion
- Dec 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of tirzepatide in obesity, sponsored by University of Virginia. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07298915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07298915.